Johnson & Johnson reported an increase in sales for its fourth quarter, largely spurred by its pharmaceutical business, but reported a loss because of effects from the new tax law.

Topics:  johnson   johnson   pharmaceutical   sales   reported   
BING NEWS:
  • Johnson & Johnson brings in billions from remaining Kenvue stake
    Johnson & Johnson has sold off its remaining stake in the Kenvue consumer products business it spun off last year.
    05/17/2024 - 5:34 am | View Link
  • Analysis of pharmaceutical R&D ranks Novo Nordisk and Johnson & Johnson above their peers
    When it comes to bringing an experimental drug to market and selling it, Novo Nordisk, maker of the weight loss drug Wegovy, is tops, according to a new analysis. #STATBreakthrough ...
    05/16/2024 - 6:25 am | View Link
  • Shockwave Medical: A Look Into Q1 Financials And Value To Johnson & Johnson Investors
    Johnson & Johnson's acquisition of Shockwave Medical is expected to benefit J&J's investors. Check out why I'm bullish on JNJ and SWAV.
    05/16/2024 - 1:44 am | View Link
  • Winners and Losers in Biopharma’s Q1 2024 Earnings Season
    The weight-loss drug bonanza continued in the first quarter of 2024 for Novo Nordisk and Eli Lilly, as Amgen also posted strong results, while Biogen and BMS struggled early in the financial year.
    05/15/2024 - 3:00 am | View Link
  • Is Johnson & Johnson Stock A Better Pick Over Merck?
    We believe that the pharmaceuticals bellwether Johnson & Johnson (NYSE: JNJ) is currently a better pick over its peer Merck (NYSE: MRK).
    05/14/2024 - 1:29 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News